Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
about
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.Recently disclosed chemical entities as potential candidates for management of tuberculosis.Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives.
P2860
Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Mycobacterium tuberculosis eno ...... evelopment in the past decade.
@en
type
label
Mycobacterium tuberculosis eno ...... evelopment in the past decade.
@en
prefLabel
Mycobacterium tuberculosis eno ...... evelopment in the past decade.
@en
P2093
P2860
P50
P1476
Mycobacterium tuberculosis eno ...... development in the past decade
@en
P2093
Martin Dolezal
Ondrej Holas
Pavel Ondrejcek
P2860
P304
P356
10.3109/14756366.2014.959512
P577
2014-11-10T00:00:00Z